Feature Channels: Immunology

Filters close
Released: 27-Mar-2020 9:00 AM EDT
Experts: Geroscience Approach May Lessen Severity of COVID-19, Bolster Older Patients’ Response to Diseases
American Federation for Aging Research (AFAR)

As the nation and world respond to the growing COVID-19 pandemic, a panel of leading aging research experts, convened by the American Federation for Aging Research (AFAR), posed that targeting the biology of aging through promising therapeutics could bolster the medical response to COVID-19 and other viruses that are devastating older patients.

Newswise: Learning from the Recovered
Released: 26-Mar-2020 9:00 AM EDT
Learning from the Recovered
Harvard Medical School

Researchers at Harvard Medical School and at Brigham and Women’s Hospital are adapting an antibody-detection tool to study the aftermath of infections by the novel coronavirus that is causing the current global pandemic.

Released: 25-Mar-2020 4:25 PM EDT
COVID-19 Immunotherapy Collab at UGA with Biotech Firm CEL-SCI to Fight Coronavirus
Newswise

CEL-SCI’s immunotherapy candidate aims to treat patients at highest risk of dying from COVID-19. LEAPS immunotherapy has been used in collaboration with the National Institutes for Allergies and Infectious Diseases (NIAID) against another respiratory virus, H1N1, involved in the 2009 H1N1 flu pandemic. Those successful studies demonstrated that LEAPS peptides, given after virus infection has occurred, reduced morbidity and mortality in mice infected with H1N1.

Released: 23-Mar-2020 2:45 PM EDT
Mount Sinai Developing an “End-to-End” Diagnostics Solution for COVID-19 That Incorporates Diagnosis, Treatment Selection, and Monitoring of Disease Course
Mount Sinai Health System

An expert team of researchers and clinicians have been working together to design, validate, and implement an “end-to-end” clinical pathology laboratory solution that will allow for the testing of approximately several hundred people per day in order to rapidly diagnose and help guide the selection of treatment and monitor disease course.

Released: 23-Mar-2020 9:30 AM EDT
CEL-SCI to Develop LEAPS COVID-19 Immunotherapy in Collaboration with University of Georgia Center for Vaccines and Immunology
Cel-Sci Corp

Initial studies with COVID-19 coronavirus aim to replicate prior successful preclinical experiments of LEAPS against H1N1pandemic flu in mice conducted with National Institutes for Allergies and Infectious Diseases (NIAID)

Newswise: Immunotherapy using ‘young cells’ offers promising option against cancer
Released: 20-Mar-2020 6:05 PM EDT
Immunotherapy using ‘young cells’ offers promising option against cancer
Washington University in St. Louis

A new study from Washington University School of Medicine in St. Louis suggests that the age of certain immune cells used in immunotherapy plays a role in how effective it is. These cells — natural killer (NK) cells — appear to be more effective the earlier they are in development, opening the door to the possibility of an immunotherapy that would not utilize cells from the patient or a matched donor. Instead, they could be developed from existing supplies of what are called human pluripotent stem cells.

Newswise: COVID-19: Can the Science of Aging Move Us Forward?
Released: 20-Mar-2020 1:25 PM EDT
COVID-19: Can the Science of Aging Move Us Forward?
American Federation for Aging Research (AFAR)

As the COVID-19 pandemic sweeps the nation and the world, the role that geroscience may play in boosting immunity in older adults and lessening the severity of age-related diseases will be explored by a panel of leading experts in the webinar, COVID-19: Can the Science of Aging Move Us Forward? The no-cost, one-hour webinar, intended for the scientific community and related science and health media, is scheduled for 1 PM EDT on Tuesday, March 24.

Released: 19-Mar-2020 12:35 PM EDT
APS Journal Research Related to Epidemics: Publicly Available Online
Association for Psychological Science

The Association for Psychological Science has made previously published journal research pertaining to epidemics and related health issues publicly available.

Newswise: COVID-19 recommendations for patients receiving anti-cancer immunotherapies
Released: 19-Mar-2020 12:05 PM EDT
COVID-19 recommendations for patients receiving anti-cancer immunotherapies
University of Colorado Cancer Center

Could medicines that activate the immune system protect against COVID-19 infection?

Newswise:Video Embedded video-and-transcript-newswise-live-covid-19-expert-panel-3-16-2020
VIDEO
Released: 18-Mar-2020 4:20 PM EDT
VIDEO AND TRANSCRIPT: Newswise Live COVID-19 Expert Panel 3-16-2020
Newswise

Newswise Live Expert Panel including experts from Newswise member institutions discussing topics related to the coronavirus and COVID-19 outbreak.


Showing results

110 of 10

close
1.19705